Asker Healthcare Group AB

ASKER.ST

Medical - Distribution · Healthcare

Exchange

Stockholm Stock Exchange

Winston Score

Winston is curious

Mixed quality — meaningful strengths and weaknesses.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Mixed

Growth

Good

Cash Flow

Strong

Stability

Good

Valuation

Good

Dividends

Mixed

Track this stock — start free trial

Winston Score History

The full picture

Asker Healthcare Group is a distributor of medical supplies and healthcare products across Europe. It sells things like surgical instruments, wound care products, and other medical consumables to hospitals, clinics, and other healthcare providers. The company acts as a middleman between manufacturers and the people who actually use the products in patient care.

Asker makes money by buying products from manufacturers and selling them to healthcare customers at a markup, which is a traditional distribution revenue model. It operates primarily in the Nordic countries and broader European markets, and its scale and established supplier relationships give it a competitive edge over smaller local distributors. The main risk the company faces is margin pressure, since distributors sit between powerful manufacturers and large hospital buyers who both push to get better prices, leaving limited room to grow profits.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

42.0%

Healthy — 42.0% gross margin

Profit after running costs

Operating Margin

7.4%

Modest — 7.4% operating margin

Return on the money invested

ROCE

9.9%

Below par — 9.9% return on capital

ROIC between 5% and 15%. They earn 5 to 15 cents back per year on every dollar invested.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

Data not available

How steady the profit is

EPS Consistency

5/5 quarters

Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

222%

Turns 222% of profit into real cash

Spare cash per sale

FCF Margin

5.5%

Thin free cash flow (5.5%)

FCF margin between 0% and 10%. Some cash from sales, but not a lot.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.77

Moderate — manageable debt (0.77)

Covers its interest

Interest Cover

2.43x

Tight — interest eats into profit (2.4x)

Interest coverage between 1 and 3. Profits cover interest, but with little room to spare.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

42.8x

no trend

Pricey — P/E 42.8

P/E over 35. The market is pricing in heavy, sustained growth.

Cheaper or dearer next year

P/E vs Forward

+21.8

GROWING

Earnings expected to grow meaningfully — cheaper on forward P/E (42.8 → 21.0)

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Dividend

Dividend Yield

2.03%

no trend

Moderate income — 2.03% yield

Standard yield zone for stable dividend payers. A meaningful piece of total return.

Dividend record

Dividend Growth

N/A

no trend

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial